Pharmaceutical companies in Bangladesh are trying to boost its pharmaceutical exports to the United Arab Emirates and Middle East as the country enjoys unique concessions as a least-developed country under World Trade Organization drug patent rules, a senior government official told the Emirates Business publication.
Bangladesh, one of the poorest South Asian countries and the 10th most populous country in the world, is currently facing a critical economic scenario due to the sharp decline in garment exports to the USA and Europe.
Mohammed Shahjalal, Assistant Director, Export Promotion Bureau under the Bangladesh Ministry of Commerce told the newspaper that the drug industry is poised to be the latest growth sector due to the favorable position as a least developed country. "We are trying to boost pharmaceutical exports to the [Gulf Cooperation Council states] and efforts are on to get registration from the UAE Ministry of Health. Many pharmaceutical companies and multinationals have expanded their production capacity in Bangladesh because, as a least-developed country, we have until 2016 to produce cheap generic drugs," he said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze